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Cp2l1Branching morphogenesis is a molecularly conserved mechanism that is adopted by several organs, such as
the lung, kidney, mammary gland and salivary gland, to maximize the surface area of a tissue within a small
volume. Branching occurs through repetitive clefting and elongation of spherical epithelial structures, called
endbuds, which invade the surrounding mesenchyme. In the salivary gland, lumen formation takes place
alongside branching morphogenesis, but in a controlled manner, so that branching is active at the distal ends
of epithelial branches while lumen formation initiates at the proximal ends, and spreads distally. We present
here data showing that interaction between FGF signaling and the canonical (β-catenin dependent) and non-
canonical branches of Wnt signaling coordinates these two processes. Using the Axin2lacZ reporter mice, we
ﬁndWnt/β-catenin signaling activity ﬁrst in the mesenchyme and later, at the time of lumen formation, in the
ductal epithelium. Gain and loss of function experiments reveal that this pathway exerts an inhibitory effect
on salivary gland branching morphogenesis. We have found that endbuds remain devoid of Wnt/β-catenin
signaling activity, a hallmark of ductal structures, through FGF-mediated inhibition of this pathway. Our data
also show that FGF signaling has a major role in the control of lumen formation by preventing premature
hollowing of epithelial endbuds and slowing down the canalization of presumptive ducts. Concomitantly, FGF
signaling strongly represses the ductal marker Cp2l1, most likely via repression of Wnt5b and non-canonical
Wnt signaling. Inhibition of canonical and non-canonical Wnt signaling in endbuds by FGF signaling occurs at
least in part through sFRP1, a secreted inhibitor of Wnt signaling and downstream target of FGF signaling.
Altogether, these ﬁndings point to a key function of FGF signaling in the maintenance of an undifferentiated
state in endbud cells by inhibition of a ductal fate.acial Development, Floor 27,
don SE1 9RT, UK. Fax: +44
ch).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The submandibular gland (SMG) belongs to a group of organs that
includes the lungs, kidneys and mammary glands, which undergo
branching morphogenesis, a process that turns a single epithelial bud
into an array of epithelial branches. Molecular mechanisms involved in
branching morphogenesis are conserved, and the mouse SMG has long
been used as a model for studying the regulation of this process. In the
mouse, SMG development begins at embryonic day 11 (E11) as an
epithelial thickening, which becomes an initial bud by E12. This initial
bud then undergoes successive rounds of clefting and elongation,
forming a network of epithelial stalks capped by endbuds, which are
spherical epithelial structures responsible for invading the surrounding
mesenchyme. In the SMG, epithelial stalks and endbuds generated
throughbranchingmorphogenesis are compact clusters of cells. As such,they require subsequent hollowing to give rise to a tubular system that
will enable the passage of saliva. Lumen formation starts at E15.5, in the
mid-stages of branching morphogenesis, in the proximal part of the
main duct and spreads distally to second order ducts, eventually
reaching themost distal parts of epithelial branches by E17.5. Therefore,
branching and lumenization appear to operate in distinct areas of the
developing gland: branching at the distal developing front and
lumenization in the oldest proximal epithelial structures. Our knowl-
edge of the regulation of lumen formation is very limited and
importantly, the molecular signals that trigger this process have yet to
be discovered. On the other hand, cellular events involved in lumen
formation in the SMG have been identiﬁed. They involve three distinct
biological processes, apoptosis of central cells (Jaskoll and Melnick,
1999; Melnick and Jaskoll, 2000), establishment of an apical–basal
polarity and formation of intercellular junctional complexes (Cutler and
Mooradian, 1987; Hashizume et al., 2004; Hashizume and Hieda, 2006;
Hieda et al., 1996) in the cells lining the lumen. Canalization of the ducts
is followed bymaturation of the epithelial cells surrounding the lumen.
In the salivary gland, ducts are not passive structures throughwhich the
saliva ﬂows; they are specialized tubes that have a physiological
function. Duct cells re-absorb and secrete solutes into the primary saliva
157N. Patel et al. / Developmental Biology 358 (2011) 156–167produced by the acini, as it passes through the lumina on its journey to
the oral cavity. Maturation of ductal cells requires expression of the
Cp2l1 gene encoding a grainyhead-related transcription factor (Yama-
guchi et al., 2006).
Wnt signaling is a highly conserved pathway, which plays a
fundamental role in a wide range of cell functions (Logan and
Nusse, 2004). Intracellularly, two pathways mediate Wnt signaling:
the canonical or Wnt/β-catenin pathway and the non-canonical or
β-catenin-independent pathway, further divided into the Wnt/Ca2+
pathway, and the planar cell polarity pathway. The Wnt/β-catenin
pathway is the most studied and best understood of these pathways.
Activation of this pathway begins with the binding of Wnt ligands to
Frizzled receptors and Lipoprotein related protein (Lrp) co-receptors
5/6. This pathway utilizes β-catenin as a transcriptional regulator. In
absence of Wnt signals, cytoplasmic β-catenin is phosphorylated by
a multiprotein complex comprising Axin, APC, glycogen synthase
kinase 3β (Gsk3β) and casein kinase I, which targets β-catenin for
proteasomal degradation. In the presence of aWnt signal, the complex
is broken down, leading to cytosolic accumulation of β-catenin,
followed by translocation of β-catenin into the nucleus, where it
interacts with LEF/TCF transcriptional repressors, leading to the
derepression of canonical Wnt target genes (MacDonald et al.,
2009). Tight control of this pathway occurs through several secreted
extracellular antagonists, which use different mechanisms to disrupt
interactions between Wnt ligands and their receptor complexes.
Secreted Frizzled related proteins (sFRPs) directly bind to Wnts
thereby preventing them from binding to the Wnt receptor complex,
whereas Dickkopf (Dkk) family members and Wise bind to the Lrp5/
Lrp6 component of the Wnt receptor complex (for a detailed review,
see Kawano and Kypta, 2003). Non-canonical Wnt signaling involves
neither Lrp coreceptors nor β-catenin stabilization (Mao et al., 2002;
Veeman et al., 2003) and regulates cell movements and planar cell
polarity (Klein and Mlodzik, 2005).
We show here that Wnt/β-catenin signaling is activated in a
dynamic fashion throughout SMG embryonic development, ﬁrst in the
condensed mesenchyme, and later in the epithelial compartment,
speciﬁcally in presumptive ducts and not endbuds. We have studied
the function and regulation of Wnt signaling in the salivary gland
epithelium and found that FGF signaling suppresses both canonical
and non-canonical Wnt activity in endbud cells. We have found that
canonical Wnt signaling inhibits branching morphogenesis, while our
data suggest that non-canonical Wnt signaling, via the Wnt5b ligand,
promotes duct maturation by positively regulating expression of
the ductal marker Cp2l1. Concomitantly, FGF signaling also controls
lumen formation by strongly inhibiting lumenization in endbuds,
while slowing down the process in presumptive ducts. FGF-mediated
inhibition of canonical and non-canonical Wnt signaling could occur
at least in part through inhibition of sFRP1, which encodes a secreted
inhibitor of Wnt signaling. Altogether, these data support a role for
FGF signaling in maintaining an undifferentiated state in the distal
epithelial branches of the developing salivary gland, which may be
crucial to allow branching morphogenesis to take place.
Materials and methods
Mouse strains
Mice of the CD-1 strain were used. The day on which the vaginal
plugs were detected was considered as embryonic day 0.5. Axin2lacZ
reporter mice were described previously (Liu et al., 2007).
Ex vivo organ culture of submandibular/sublingual glands
CD1 submandibular/sublingual gland rudiments were cultured at
the air/medium interface on Whatman Nuclepore Track-Etched
membranes 13 mm diameter, 0.1 μm pore size (Whatman, ScientiﬁcLaboratory Supplies Ltd) inorgan culturedishes (Falcon,BDBiosciences)
as previously described (Hoffman et al., 2002). The membranes were
ﬂoated onto 200 μl of advanced DMEM/F12 (Invitrogen) supplemented
with 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM L-glutamine,
150 μg/ml ascorbic acid and50 μg/ml transferrin.Up to six salivary gland
rudiments were cultured on each ﬁlter at 37 °C in a humidiﬁed 5% CO2
atmosphere. Culture medium was changed every day. Glands were
photographed at 0 h, 24 h and 48 h. In supplementation studies, salivary
glands were cultured overnight in the presence of 20 μM SB415286
(Sigma), 50 μM SU5402 (Calbiochem, UK), 25 mM LiCl, 2.5 μg/ml
recombinant Mouse Dkk1 or 2.5 μg/ml recombinant Human sFRP1
(R&DSystems). Controls consisted ofmediumsupplementedwith equal
volumes of DMSO (SB415286 and SU5402), water (LiCl), 0.01% BSA
(Dkk1) and 1× PBS (sFRP1). Right and left glands of a same pair were
cultured respectively with supplemented and control medium. The
number of end buds of each explant was assessed at the beginning and
end of experiments using ImageJ. Spooner ratios (ﬁnal endbud number/
initial endbudnumber (Spooner et al., 1989))were determined for each
explant, and compared by paired t-test.Ex vivo organ culture of mesenchyme-free submandibular epithelium
Culture of mesenchyme-free epithelia was performed as previ-
ously described (Steinberg et al., 2005) with some modiﬁcations. E13.5
salivary gland rudiments displaying up to 6 buds were dissected and
incubated in 3.5 U/ml of Dispase (Roche) in DMEM/F12 medium
(Invitrogen) with 2% BSA for 20 min. Epithelial rudiments were quickly
separated from the surrounding mesenchyme using ﬁne needles while
still in the enzymatic solution and washed two times in DMEM/F12
before being transferred onto Nuclepore ﬁlters. Isolated epithelia were
individually covered with a 2 μl drop of Cultrex 3D laminin 111 (R&D
Systems) and cultured in culturemediumsupplementedwith 500 ng/ml
recombinant human FGF10 (R&D Systems) and 0.05 μg/ml heparin
sodium salt (Sigma).Preparation of RNA and cDNA and quantitative real-time PCR
RNAwas extracted from single salivary glands using RNAeasymicro
kit (Qiagen) with DNAse treatment (DNA-free kit, Ambion). cDNA was
prepared from 250 ng of RNA using M-MLV reverse transcriptase
(Promega). Three cDNA samples (corresponding to three distinct
glands) were obtained for each culture condition. Real-time PCR was
performed using GoTaq qPCRMasterMix (Promega) with a Rotor-gene
Q thermocycler (Qiagen). cDNA was ampliﬁed with 40 cycles of 95 °C
for 5 s, then 60 °C for 10 s and 72 °C for 10 s. Primers used for Axin2
(5′-gagagtgagcggcagagc; 5′-cggctgactcgttctcct), Cp2l1 (5′-gcggtgaagc-
tacatgaagag; 5′-tggaagtcccctagcttcc), GAPDH (5′-ccatggagaaggctgggg;
5′-caaagttgtcatggatgacc) and β-actin (5′-ctaaggccaaccgtgaaaag; 5′-
accagaggcatacagggaca) generated respective amplicons of 104, 95, 195
and 104 bp. Serial dilution of the control cDNA and melt-curve analysis
were performed to conﬁrm that a single product was ampliﬁed. Gene
expression was normalized to GAPDH or β-actin and all reactions were
run in triplicate. Each experiment was repeated at least three times.Histology and β-galactosidase staining
Axin2lacZ/+ salivary glands were isolated and either submitted
immediately to X-gal staining or X-gal stained following in vitro
culture for 1 h (E12.5 and E13.5 stages) or 2 h (E14.5 stage). Salivary
glands were ﬁxed in 1.97% formaldehyde, 0.2% glutaraldehyde, 0.02%
Igepal for 30 min on ice, washed three times 5 min in 1×PBS,
transferred into X-gal solution and stained overnight at 37 °C. After
staining, salivary glands were washed in 1×PBS and post-ﬁxed in 4%
paraformaldehyde. 8 μm sections were counterstained with eosin.
Fig. 1. Spatial and temporal pattern of activeWnt/β-catenin signaling. (A–M)Axin2lacZ/+
SG stained for β-gal activity. (A, B) At early stages of SG development, β-gal activity is
found in the mesenchyme facing the SMG (black arrowheads), and surrounding the
SMG and SLG main ducts. The mesenchyme facing the SLG appears devoid of β-gal
activity (red arrowheads). (C) At E13.5, no β-gal staining can be found in epithelial
structures. (D) In E14.5 SG, β-gal activity is still observed in the mesenchyme facing the
SMG (black arrowhead) and remains absent in the mesenchyme facing the SLG (red
arrowhead). β-gal activity is also present in the SMG main duct while it is down-
regulated in the mesenchyme surrounding it (E). A similar switch is observed shortly
after for the SLG, whose development lags one day behind the SMG (F). At E15.5, some
lumina are lined by epithelial cells devoid of β-gal activity (G, arrowhead). E18.5 SG display
strong β-gal activity throughout the ducts (d) of both glands and not the acini (a) (H, I).
Not all intercalated ducts (int) display β-gal activity (J, K arrowheads). (L, M) Higher
magniﬁcation shows β-gal activity in the mesenchyme surrounding the ducts, including
ﬂat cells lining the walls of the ducts (green arrowheads) and more distant cells (white
arrowheads). Sections are stained with periodic acid Schiff (I–K) or eosin (G, L, M). Scale
bar represents 400 μm in A, 300 μm in B, 100 μm in C, E, F, I, J, K, 250 μm in D, 50 μm in G,
800 μm in H and 30 μm in L and M.
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Salivary glands were ﬁxed with MEMFA (100 mM MOPs, 2 mM
EGTA, 1 mM MgSO4 and 3.7% formaldehyde) for 1 h at room
temperature (RT), permeabilized with 1% Triton X-100 and 1% BSA for
up to 1.5 h at RT and then blocked overnight at 4 °Cwith blocking buffer
(1% TritonX-100, 1% BSA and 20% heat inactivated goat serum). Salivary
glands were incubated with mouse anti-β-catenin (C7202, Sigma),
rabbit anti-PKCζ (sc-216, Santa-Cruz Biotechnology) or rabbit anti-
active caspase 3 (Abcam) in blocking buffer overnight at 4 °C, followed
byovernight incubation at4 °CwithAlexa488anti-mouse or anti-rabbit
antibody and DAPI (Molecular Probe, Invitrogen) in blocking buffer.
Images were obtained using a Leica TCS SP5 confocal microscope.
Whole-mount in situ hybridization (WISH)
WISH was performed as described (Mootoosamy and Dietrich,
2002) on isolated E13.5 salivary glands cultured ex vivo for either 1 h
or overnight in inhibitor studies.Wnt5b probe was obtained from the
IMAGE Consortium with IMAGE ID 6438917. sFRP1 was a gift from
Ramesh Shivdasani, Er81, Erm, Pea3, cyclinD1, Spry1-2-4 were gifts
from Albert Basson. Cp2l1 probe was obtained by PCR (5′-tcaggg-
caatgctgtggccg; 5′-cagggcagccacgtgggaag).
Results
Wnt/β-catenin signaling is active at all stages of salivary gland
development
To investigatewhetherWnt/β-catenin is active during salivary gland
(SG) development, we used the Axin2lacZ reporter mice. In this
transgenic mouse line, the lacZ reporter gene has been knocked in
into the Axin2 gene (also known as Conductin or Axil), which is a direct
downstream target ofWnt/β-catenin signaling (Clevers, 2006; Jho et al.,
2002; Leung et al., 2002; Lustig et al., 2002). From E12.5 to E18.5, β-
galactosidase (β-gal) activity was detected at all stages of Axin2lacZ/+ SG
development. At early stages of SG development, active Wnt/β-catenin
signaling was restricted to the SG condensed mesenchyme (Fig. 1A–C)
and from E14.5 onwards it was also present in the epithelium (Fig. 1D–
M). At the initial bud stage (E12.5), Axin2-lacZ activity was found in the
mesenchyme adjacent to the oral epithelium as well as in the SG
condensed mesenchyme facing the tip of the epithelial bud of the
submandibular gland (SMG), on the lingual side of thegland (Fig. 1A). At
E13.5, the sublingual gland (SLG) has reached an initial bud stage and
penetrated the capsular rudiment of the SMG, while the SMG starts
undergoing branching morphogenesis. β-gal activity was detected in
the mesenchyme facing the SMG and in the mesenchyme surrounding
the main ducts of both glands (Fig. 1B). No β-gal activity was found in
the SMG and SLG epithelium (Fig. 1C). At the pseudoglandular stage
(E14.5), β-gal activity was still detected in the mesenchyme facing the
SMG. Interestingly, themesenchyme facing the SLGwas devoid of β-gal
activity, although the SLG had reached a developmental stage similar to
the one of the SMG at E13.5 (Fig. 1D), indicating that the lack of active
Wnt/β-catenin signaling in themesenchyme facing the SLGat E13.5was
not the consequence of SLG development lagging behind SMG
development. At E14.5, while β-gal activity was strong in the
mesenchyme surrounding the main duct of the SLG, it was down-
regulated in the mesenchyme surrounding the SMG main duct and
concomitantly up-regulated in the epithelium of this duct (Fig. 1E).
Similar down-regulation of β-gal activity in the mesenchyme, associ-
ated with epithelial activation, was observed shortly after for the SLG
main duct (Fig. 1F). At the canalicular stage (E15.5), epithelial β-gal
activity had spread from themain ducts to smaller ducts. This coincided
with the onset of lumen formation, yet closer examination of hollowing
epithelial stalks demonstrated that activation of Wnt/β-catenin signal-
ingwas not required for lumen formation. Indeed, nascent luminawere
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data suggests that activation of Wnt/β-catenin signaling in ductal
epithelium is involved in duct maturation. At the terminal differenti-
ation stage (E18.5), active Wnt/β-catenin was observed in most ducts
and not in the acini (Fig. 1H–J), with some intercalated ducts visibly
devoid of Wnt/β-catenin activity (Fig. 1K). Closer observation of ductal
structures revealed that the surrounding mesenchyme displayed β-gal
staining, including ﬂat cells lining the wall of the ducts as well as loose
mesenchyme at the periphery (Fig. 1L, M).
Forced activation of Wnt/β-catenin signaling leads to an arrest of
epithelial branching
The analysis of Axin2lacZ/+ SGs revealed that in the SG epithelium,
Wnt/β-catenin was only active in ductal structures, being switched on
around the time of initiation of lumen formation and spreading from
proximal to distal epithelial structures, in a similar fashion to the
canalization process. At early stages of SG development the epithelium
was devoid ofWnt/β-catenin signaling, in contrast to observations made
in other branching organs. To assess the importance of a lack of Wnt/β-
catenin signaling in the early developing SG epithelium, we tried to
constitutively activateWnt/β-catenin signaling in the epithelial compart-
ment, by inhibiting GSK3β, which normally phosphorylates β-catenin,
thereby targeting it for proteasomal degradation.We used two inhibitors
of GSK3β, SB415286 and LiCl, to constitutively stimulate Wnt/β-catenin
activity. E13.5 wild-type (WT) SMGs cultured with 10–40 μM SB415286
exhibited a complete arrest of branching after 24 h, when compared to
DMSO-treated control SMGs (Fig. 2A). Analysis of the glands after 48 h of
culture in the presence of SB415286 revealed that branching morpho-
genesis either recovered at 10 μM, or remained arrested at 20 and 40 μM.
40 μM SB415286 appeared to affect endbud cell viability and therefore,
SB415286 was used at 20 μM in further experiments. LiCl appeared to
have a similar inhibitory effect on branching (Fig. 2A). Endbuds of
SB415286-treated SMGs appeared enlarged after 24 h of culture (Fig. 2A)
with a complete absence of new clefts at their tip (Fig. 5I, K), suggesting
that the mechanism involved in cleft formation was impaired in the
presence of ectopic or excessive Wnt/β-catenin signaling. Treatment of
younger SGs (E12.5) with SB415286 led to a similar arrest in branching
with failure of cleft formation (data not shown). Axin2lacZ/+ SMGs
cultured with SB415286 exhibited a sharp increase in β-gal staining.
Increase in β-gal activity was prominent in the mesenchyme and had
extended to the mesenchyme surrounding the SLG, normally devoid of
active Wnt/β-catenin signaling (Fig. 2B). Sections through SB415286-
treated SMGs showed that these glands exhibited an increase in
mesenchymal Wnt/β-catenin signaling as well as ectopic epithelial
Wnt/β-catenin signaling. Salt-and-pepper Axin2-lacZ activity was
detected throughout the epithelial endbuds (Fig. 2B). In order to
investigate whether ectopic epithelial Wnt/β-catenin signaling was
responsible for the arrest in branching morphogenesis, we cultured
isolated E13.5 SMG epithelium in the presence of SB415286. Axin2lacZ/+
isolated epithelia cultured for 24 h in the presence of SB415286 displayed
extensiveβ-gal stainingwhile control epithelia were devoid of Axin2-lacZ
activity (Fig. 2C). Control epithelium treated with DMSO formed
numerous long, thin branches, whereas epithelium cultured in the
presenceof SB415286didnot, indicating that ectopic activation ofWnt/β-
catenin signaling in the epithelium is sufﬁcient to inhibit branching
(Fig. 2C). The surface area occupied by SB415286-treated epithelia
increased over a three day culture period, showing that epithelial cell
proliferation is not affected in absence of GSK3β activity.
FGF signaling negatively regulates Wnt/β-catenin activity in SMG
epithelium
The FGF receptor (FGFR) inhibitor SU5402 inhibits branching
morphogenesis by decreasing epithelial cell proliferation (Hoffman
et al., 2002). In the absence of FGF signaling, epithelial endbuds do notenlarge and form ﬁnger-like projections that fail to branch (Fig. 3A
and 5A). Since constitutive activation of Wnt/β-catenin signaling in
SMG epithelium appeared to be incompatible with branching
morphogenesis, we tested whether Wnt/β-catenin signaling was
altered in SMGs lacking FGF signaling. SU5402-treated Axin2lacZ/+ SGs
displayed strong ectopic β-gal activity throughout the entire
epithelial compartment, while in control SMGs, β-gal activity was
restricted to the proximal part of the main excretory ducts (Fig. 3B).
These data demonstrate that during branching morphogenesis, FGF
signaling acts upstream of Wnt/β-catenin signaling in the SMG
epithelium and inhibits Wnt/β-catenin signaling.
Although previous studies have reported expression of Fgf and Fgfr
transcripts in both the epithelium and the mesenchyme of the
developing SMGs at E13.5 (Hoffman et al., 2002), it is unclear whether
FGF signaling takes place simultaneously in both tissues during
branching morphogenesis. For example, at E13.5, while expression of
Fgfr1b and Fgfr1c has been detected respectively in the epithelium and
the mesenchyme (Hoffman et al., 2002), Fgfr1 was localized
throughout the epithelium only (Steinberg et al., 2005). In order to
identify sites of active FGF signaling in E13.5 SMGs, we analyzed the
expression of FGF target genes in this tissue. We identiﬁed seven FGF
target genes in E13.5 SMGs, comprising the ETS-domain transcription
factors Erm, Pea3 and Er81, the FGF antagonists Sprouty1 (Spry1),
Sprouty2 (Spry2) and Sprouty4 (Spry4) and the regulator of cell
proliferation cyclinD1. Expression of these seven genes was dramat-
ically reduced in SMGs treated with SU5402 (Fig. 3C) conﬁrming that
they are downstream targets of FGF activity in this tissue. At E13.5,
expression of Erm, Pea3 and cyclinD1 was restricted to epithelial
endbuds, while expression of Spry1 and Spry2 was found in both
epithelial endbuds and epithelial stalks (Fig. 3C). Expression of these
ﬁve epithelial genes was noticeably absent in the outer layer of
epithelial cells in contact with the basementmembrane (Fig. 3C). Er81
and Spry4 were expressed both in the epithelium and in the
mesenchyme. In the mesenchyme, expression was restricted to a
few layers of cells lining the endbuds and proximal part of the main
duct and was particularly strong in the interbud spaces (Fig. 3C).
These experiments suggest that at E13.5, FGF signaling is active in the
epithelium as well as in a thin layer of mesenchymal cells covering the
endbuds and the proximal part of the main duct.
The ductal markers Cp2l1 and Wnt5b are ectopically expressed in
endbuds in absence of FGF signaling
The Axin2lacZ reporter line revealed that activation ofWnt/β-catenin
signaling in salivary gland epithelial cells is restricted to ductal
structures. Since Wnt/β-catenin signaling was ectopically activated in
endbud cells in absence of FGF signaling or GSK3β activity, we thought
to investigate whether endbud cell identities were altered.We used the
ductal marker CP2-like 1 (Cp2l1), a grainyhead-related transcription
factor, to examine cell differentiation in our ex vivo explants. Cp2l1 is
speciﬁcally expressed in developing epithelial tubes that actively
transport ﬂuids, including the ducts of the SGs and several other
exocrine glands. In the SG, where the ducts are sites of saliva
modiﬁcation, Cp2l1 is required for proper maturation and physiological
function of the ducts, leading to saliva with abnormal electrolyte
composition in Cp2l1 mutant mice (Yamaguchi et al., 2006). Cp2l1 is
expressed in the presumptive ductal epitheliumof developing SMG and
SLG as early as the initial bud stage (Fig. 4A). Throughout branching
morphogenesis, Cp2l1 expression is observed in all epithelial stalks
(Fig. 4A, B) as well as in small groups of endbuds cells lying adjacent to
duct epithelium (Fig. 4C). Importantly, Cp2l1 is not expressed in endbud
cells other than those found near the endbud/duct junction. Salivary
glands treated with either SB415286 or SU5402 both exhibited ectopic
Cp2l1 expression in endbuds compared to DMSO-treated controls
(Fig. 4D–I).Cp2l1deregulationwasnoticeably stronger in the absence of
FGF signaling than following inhibition of GSK3β, since SU5402-treated
Fig. 2. Constitutive activation of Wnt/β-catenin signaling using GSK3β inhibitors results in an arrest of branching morphogenesis. (A) E13.5WT SGs cultured for 24 h in the presence
of SB415286 (10–40 μM) and LiCl (25 mM) show an arrest in epithelial branching (third column). After 48 h of culture, branching recovers with 10 μM SB415286, whilst it remains
arrested with 20 and 40 μM of SB415286 and LiCl (ﬁfth column). SGs treated with 40 μM SB415286 do not appear healthy after 48 h of culture. (B) Increase in β-gal staining in
SB415286-treated Axin2lacZ/+ SGs compared to DMSO-treated SGs. Eosin counterstained sections reveal that in addition to increased mesenchymal Wnt/β-catenin signaling, ectopic
β-gal activity is evident throughout the epithelium, including the SMG endbuds (bottom row). (C) Isolated E13.5 SMG epithelium cultured in the presence of 20 μM SB415286 stops
branching although it continues to grow in size (top row). DMSO-treated epithelium forms multiple branches (bottom row). Axin2lacZ/+ isolated epithelia exhibit ectopic LacZ
staining after 24 h in the presence of SB415286 (ﬁfth column). Scale bar represents 250 μm in A, B (top row), C and 50 μm in B (bottom row).
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structures associated with broad Cp2l1 ectopic expression in endbuds
(Fig. 4D, E). Close examinationof endbudswith ectopicCp2l1 expression
conﬁrmed thatCp2l1 ectopic expressionwasmore extensive in SU5402-
than SB415286-treated SGs (Fig. 4F, I). Furthermore, while ectopic
expressionofCp2l1wasstronganduniform in thepresence of SU5402, it
was weaker and uneven with SB415286. Cp2l1 expression domain also
appeared to have a variable shape in endbuds lacking GSK3β activity
(data not shown). Despite extensive ectopic expression of Cp2l1 in
endbuds of SU5402-treated SMGs, a multilayer of cells, located around
the periphery of the endbuds remained devoid of Cp2l1 expression
(Fig. 4F). These results reveal that despite SU5402- and SB415286-
treated SGs exhibiting similar levels of Wnt/β-catenin signaling in
endbuds (a ductal feature), it correlates with widespread ectopic
expressionof theductalmarkerCp2l1only in SU5402-treatedSGs. Cp2l1
coordinates the expression of several genes involved in terminaldifferentiation of ductal epithelium (Yamaguchi et al., 2006), suggesting
that an absence of FGF signaling drives endbud cells from an immature,
undifferentiated state to a ductal fate. Furthermore, upregulation of
Cp2l1 in the ductal epithelium following treatment with SU5402 hints
that FGF signaling represses a ductal fate not only in endbuds but also in
presumptive ducts.
The Cp2l1 gene was isolated in a screen for Wnt signaling targets
(Yamaguchi et al., 2005). However, our data reveal that in the SG it is
not a target of Wnt/β-catenin signaling, as Wnt/β-catenin signaling is
activated at E14.5 in the SMG main duct (Fig. 1D), while Cp2l1 is
already expressed in presumptive ducts at E13.5 (Fig. 4A). We found
that the non-canonical Wnt ligand Wnt5b was expressed in
presumptive ducts (Fig. 4J, K), but not endbuds of developing SMGs
(Fig. 4L), in a similar manner to Cp2l1, suggesting that Cp2l1 is a target
of the non-canonical Wnt pathway. Consistent with this, endbuds of
SU5402- and SB415286-treated SMGs exhibited ectopic expression of
Fig. 3. FGF signaling inhibits Wnt/β-catenin activity in the SMG epithelium at the pseudoglandular stage. (A) E13.5 WT SGs cultured for 24 h with 50 μM SU5402 show an arrest of
branching with characteristic ﬁnger-like projections compared to DMSO-treated control SMGs. (B) β-gal staining in E13.5 Axin2lacZ/+ SGs cultured for 24 h with 50 μM SU5402 or
control DMSO. In DMSO-treated control SGs, Axin2-LacZ activity in the epithelium is restricted to the proximal part of the SMG main duct. In SU5402-treated SGs, β-gal activity is
abnormally found in the distal part of the main duct and in endbud cells of the SMG. Axin2-LacZ activity appears unchanged in the mesenchyme. Sections through endbuds of these
Axin2lacZ/+ SMGs are shown on the right. SU5402-treated SMGs exhibit numerous lacZ-positive cells, including the outermost cell layer of endbuds, adjacent to the basement
membrane (arrowhead). No Axin2-LacZ activity was detected in endbuds of DMSO-treated SMGs. (C) FGF signaling is active in all epithelial cells of E13.5 SMGs as well as in a few
layers of mesenchymal cells adjacent to the endbuds and proximal part of the main duct. Whole-mount in situ hybridization for Er81, Erm, Pea3, cyclinD1, Spry1, Spry2 and Spry4
performed on E13.5WT SGs (ﬁrst row) and E13.5WT SGs cultured for 24 hwith 50 μM SU5402 (third row) or DMSO (fourth row). Higher magniﬁcation of expression of these genes
in E13.5 WT endbuds is shown in the second row, alongside increased expression of Er81 and Spry4 in interbud mesenchyme. Expression of the ﬁve epithelial genes was distinctly
absent in the outermost epithelial cell layer in contact with the basement membrane (arrowheads). Scale bars represent 250 μm (A and left column in B), 30 μm (right column in B),
200 μm (ﬁrst, third and fourth rows in C), 25 μm (second row in C).
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expression of Wnt5b appeared stronger and more extensive in
SU5402- than SB415286-treated SGs. In conclusion, in the absence of
either FGF signaling or GSK3-β activity both Wnt/β-catenin signaling
and non-canonical Wnt signaling (NCWS) are ectopically activated inendbud cells. Although ectopic activation of Wnt/β-catenin signaling
is strong in both SU5402- and SB415286-treated SMGs, ectopic
activation of NCWS is more extensive in the presence of SU5402.
Activation of NCWS via the Wnt5b ligand most likely results in
expression of the ductal marker Cp2l1.
Fig. 4. Cp2l1 andWnt5b expression in SMG epithelium with constitutively active Wnt/β-catenin signaling. Whole mount in situ hybridization for Cp2l1 andWnt5b in E13.5 (A, J) and
E14.5 (B, K) WT SGs and E13.5 SGs treated for 24 h with SU5402 (D, M) and SB415286 (G, P), with respective DMSO-treated controls (E, N and H, Q respectively). Higher
magniﬁcation of endbuds in (A, D, G, J, M, P) are shown in (C, F, I, L, O, R) respectively. Endbuds are outlined with dashed lines in (C, F, I, O, R). Cp2l1 is expressed in the presumptive
ductal epithelium (A, B) and in a small group of endbud cells around the endbud/duct junction (C), similar toWnt5b (J–L). Cp2l1 is ectopically expressed in the endbuds of SGs treated
with SU5402 and SB415286 (D, G respectively), compared to DMSO controls (E, H). Similar ectopic expression of Wnt5b is found in endbuds in absence of FGF signaling (M, N) or
Gsk3-β activity (P, Q). Note that Cp2l1 and Wnt5b expression also appears stronger in the main duct of SU5402-treated SGs (D, M), compared to DMSO-treated control SGs (E, N).
Cp2l1 ectopic expression in endbuds is uniform, stronger and more extensive with SU5402 (F) than SB415286 (I). A few epithelial cell layers at the periphery of the endbuds do not
express Cp2l1 and Wnt5b (F, I, O, R arrowheads). Scale bar represents 200 μm in A and 50 μm in C.
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We further examined the epithelial structure of SGs devoid of FGF
signaling by labeling the cell cytoplasmic membranes with an
antibody directed against β-catenin. Inmammalian epithelia, besides
the free pool of β-catenin involved in Wnt/β-catenin signaling, most
of the cellular β-catenin is sequestered at the cell membranes in
adherens junctions. After 24 h treatment with SU5402, the epithelium
of the SMG displayed small, separated intercellular spaces (Fig. 5A, B)
that extended into the ﬁnger-like projections of endbuds (Fig. 5C),
while no gap or epithelial discontinuities were found in endbuds of
control SMGs (Fig. 5D). By 48 h of SU5402 treatment, dramatic
hollowing of the presumptive ducts had occurred (Fig. 5E, F) and
epithelial gaps in endbuds had expanded further (Fig. 5F, G) with
some of these communicating with the main duct cavity. In contrast,
at 48 h, lumen formation had just initiated in the main duct of control
SMGs (Fig. 5H). SB415286-treated SMGs exhibited no epithelial
discontinuities in endbuds (Fig. 5I, K) and lumen began to form in the
SMGmain duct at 48 h (Fig. 5J), similar to control SMGs (Fig. 5H). This
result indicates that the extensive hollowing observed in SU5402-
treated SMGs is not the consequence of an arrest in branching
morphogenesis. Interestingly, in SU5402-treated SMGs, β-catenin was
absent from the cell membranes facing the epithelial gaps (Fig. 5C, G),
a feature observed in all polarized epithelial cells lining a lumen
(Fig. 5L), suggesting that the epithelial cells lining the gaps had
acquired an apical–basal polarity. To determine whether epithelial
gaps found in the absence of FGF signaling corresponded to lumen
that were forming prematurely in epithelial stalks and ectopically in
endbuds, we looked at the apical membrane marker atypical protein
kinase C (aPKC). In WT SMGs, aPKC was present in apical membranes
facing the central lumen (Fig. 5P) at E16.5. Epithelial gaps found in
SU5402-treated SMGs were consistently lined by aPKC-positive
membranes (Fig. 5M, N), both in endbuds and presumptive ducts,while endbuds of control SMGs were devoid of aPKC staining
(Fig. 5O). In salivary glands, lumina form following the death by
apoptosis of the cells located in the center of the epithelial stalks
(Jaskoll and Melnick, 1999; Melnick et al., 2001). Apoptosis was
detected in presumptive ducts and endbuds cells of SMGs deprived of
FGF signaling, as revealed by the presence of the active form of
caspase-3 (Fig. 5Q, R), while it was not detected in epithelial cells of
control SMGs (Fig. 5S). Altogether, these data show that during
branching morphogenesis, an absence of FGF signaling leads to an
early canalization of presumptive ducts as well as the formation of
ectopic lumen in endbuds. Abnormal lumen formation appears to use
the same mechanisms as those used during normal SMG develop-
ment, namely the creation of a lumen by programmed cell death and
the polarization of the epithelial cells lining the lumen. SB415286-
treated endbuds, which display variable, weak and patchy Cp2l1
expression, do not undergo such early lumenization.
The Wnt inhibitor sFRP1 is a target of FGF signaling in epithelial endbuds
and acts as an inhibitor of Wnt signaling during branching
morphogenesis
We next investigated if FGF-mediated inhibition of Wnt signaling
involved a known secreted inhibitor of the Wnt pathway. Having
established that at E13.5, FGF signaling inhibits both canonical and non-
canonical Wnt signaling in epithelial cells and that FGF target genes
appear to be active in all epithelial cells as well as a thin layer of
mesenchyme lining the endbuds and proximal part of themain duct, we
examined whether we could identify a Wnt inhibitor gene with an
expression fulﬁlling two criteria: 1) following a pattern similar to the
one of a known FGF target gene in SMGs and 2) inhibited in the absence
of FGF signaling. We studied the expression pattern of sFRP1-5, Dkk1-4
and Wise in E13.5 WT SGs and SGs treated with SU5402. We found
that all of these genes were expressed at E13.5 (data not shown), but
Fig. 5. Absence of FGF signaling leads to premature lumen formation. Whole SGs immunostained with β-catenin (A–L), aPKCζ (M–P) and active caspase 3 (Q–S) and imaged by
confocal microscopy. Low and highmagniﬁcation images of E13.5WT SMGs treatedwith SU5402 for 24 h reveal a number of small intercellular spaces in the epithelium (A–C). These
gaps are also found in the ﬁnger-like projections of the endbuds (B, C, arrowheads). In contrast, epithelial cells are tightly packed in control endbuds (D). After 48 h of SU5402
treatment, the initially small intercellular spaces were remarkably larger (E) and in some places continuous with the main presumptive duct (E, F, arrowhead). Low magniﬁcation
image of the control SG shows that lumen formation has just begun in the presumptive main duct after 48 h of culture (H, arrowhead). β-catenin is not found in apical cell
membranes facing the epithelial spaces in SU5402-treated SGs (C, G arrowheads). Similarly, β-catenin is also absent in apical cell membranes lining the lumen at E16.5
(L, arrowhead). E13.5WT SMGs treated with SB415286 for 24 and 48 h do not reveal any epithelial spaces in the endbuds (I, K) and after 48 h show a beginning of lumen formation in
the presumptive main duct (J, arrowhead) similar to the control endbuds and main duct (D, H respectively). SB415286-treated SMGs do not show any signs of new cleft formation
after both 24 and 48 h of culture, numbers indicate individual endbuds present at the start of culture (I, K). The apical cell membranemarker aPKCζ lines all the epithelial intercellular
spaces in SMGs treated for 48 h with SU5402, including those in the ﬁnger-like projections (M, N). Similar localization of aPKCζ is detected in the lumen of E16.5 WT SGs (P). aPKCζ
was not detected in the endbuds of control SMGs (O). Active caspase 3 is found localized in areas of the presumptive ducts and endbuds corresponding to the intercellular spaces
found in SMGs treated for 24 hwith SU5402 (Q, R). In contrast, epithelial cells of control SMGs do not exhibit active caspase 3 (S). Scale bar represents 100 μm in A, E, H, J, Q, S, 50 μm
in B, F, M, 30 μm in I, K, R, and 15 μm in C, D, G, L, N, O, P.
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signaling. At E13.5, sFRP1 expression was localized in endbud cells, and
E13.5 WT SGs treated with SU5402 showed a complete loss of sFRP1
expression (Fig. 6A), demonstrating that sFRP1 is a downstreamtarget of
FGF signaling.
Mechanisms by which sFRPs alter Wnt signaling are still unclear,
since these proteins can have opposing effects on the pathway. In
addition, sFRPs also have non-Wnt related functions, antagonizingBMP signaling (Misra and Matise, 2010). In order to investigate
whether sFRP1 can modulate Wnt signaling in E13.5 SMGs, we
studied the effect of an excess of sFRP1 on SMG branching. WT E13.5
SGs were treated with a range of recombinant sFRP1 concentrations,
and we found that sFRP1 promoted branching morphogenesis in a
concentration-dependent manner. sFRP1-treated SMGs exhibited up
to 26%more endbuds than control SMGs (Fig. 6B, C). To conﬁrm that a
down-regulation of Wnt/β-catenin signaling results in an increase in
Fig. 6. sFRP1, a target of FGF signaling, negatively regulatesWnt/β-catenin signaling and Cp2l1 expression. (A) sFRP1 is a target of FGF signaling. Wholemount in situ hybridization for
sFRP1 on E13.5WTSMGs, and E13.5WTSMGs cultured for 24 hwith 50 μMSU5402 orDMSO,which reveals that sFRP1 is not expressed in absence of FGF signaling. (B, C) Recombinant
sFRP1 andDkk1 promote branchingmorphogenesis. (B) Pairs ofWT SMGs treatedwith either 2.5 μg/ml recombinant sFRP1 or Dkk1 protein, compared to controls respectively treated
with PBS and BSA. Following 24 h of culture, SMGs treated with recombinant protein displayed more endbuds than the control pairs. (C) Graphical representation of mean Spooner
ratio of E13.5 WT SMGs following 24 h culture with 1.25 μg/ml or 2.5 μg/ml recombinant sFRP1 compared to PBS-treated control SMGs. A 17% (n=17), 26% (n=12) and 22.6%
(n=12) increase in endbuds was observed with 1.25 and 2.5 μg/ml sFRP1 and 2.5 μg/ml Dkk1 respectively. (D) Recombinant sFRP1 negatively regulates Axin2 and Cp2l1 expression.
Analysis of Axin2 and Cp2l1 expression by real-time PCR, normalized to GAPDH expression, in SMGs cultured for 24 h in the presence of 2.5 μg/ml recombinant sFRP1 or control
PBS. Recombinant sFRP1 decreases Axin2 and Cp2l1 expression by 43% and 40% respectively. Similarly, the relative expression level of Axin2 was compared by real-time PCR,
normalized to β-actin, in E13.5 WT pairs of SMGs treated with 2.5 μg/ml recombinant Dkk1 protein or BSA control. A 70.7% reduction in Axin2 expression was in SGs cultured in
the presence of recombinant Dkk1 protein detected compared to BSA-treated control SMGs. (E, F) Recombinant sFRP1 is not sufﬁcient to rescue ectopic expression of Cp2l1 found
in SU5402-treated SMG endbuds. Whole-mount ISH for Cp2l1 performed on SMGs cultured for 24 h in the presence of SU5402 with either 2.5 μg/ml recombinant sFRP1 or control
PBS. Ectopic expression of Cp2l1 in epithelial endbuds appears unchanged in the presence of sFRP1 (E). (F) Analysis of Axin2 and Cp2l1 expression by real-time PCR, normalized
to GAPDH, in SMGs cultured for 24 h with SU5402 or control DMSO reveals a 2370% increase in Axin2 and a 1409% increase in Cp2l1 levels in SMGs treated with SU5402
compared to control SMGs. The same analysis carried out in SMGs treated with SU5402+2.5 μg/ml sFRP1 shows a reduction in Axin2 and Cp2l1 levels of 36% and 33%
respectively. Graphical representations of Axin2 and Cp2l1 levels of expression in the SU5402+PBS control are shown identical to those found in the SU5402 experiment. p
values are paired Student t-tests, *pb0.05, **pb0.01. Error bars are standard error±mean. Scale bar represents 200 μm.
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recombinant Dkk1 protein. Dkk1 speciﬁcally inhibits Wnt/β-catenin
signaling; it acts outside the cells, where it forms a complex with
the Wnt co-receptors Lrp5/6 (Baﬁco et al., 2001; Mao et al., 2001;
Semenov et al., 2001) and Kremen transmembrane proteins (Mao et
al., 2002), promoting the internalization of LRP, which then becomes
unavailable for Wnt reception. WT SGs were treated with 400 ng/ml,
800 ng/ml, and 2.5 μg/ml Dkk1 protein for 24 h. No change in SMG
development was observed at the two lower Dkk1 concentrations
(data not shown). However, 2.5 μg/ml of Dkk1 led to SMGs displaying
a signiﬁcantly higher number of endbuds, with Dkk1-treated SMGs
containing 22.6% more endbuds than control SMGs (Fig. 6B, C). Theseresults suggest that during branching morphogenesis, mesenchymal
Wnt/β-catenin signaling inhibits epithelial branching. Real-time PCR
analysis showed respective decreases of 43% and 40% in Axin2 and
Cp2l1 expression following addition of sFRP1 and 70.7% in Axin2
expression following addition of Dkk1 (Fig. 6D). Taken together, these
results indicate that sFRP1 acts as an inhibitor of Wnt signaling (both
canonical and non-canonical) at the pseudoglandular stage of SMG
development. To identify whether sFRP1 normally prevents Wnt
signaling activation in endbud cells of developing SMGs, we
attempted to restore the levels of sFRP1 protein in SMGs deprived
of FGF signaling. Blockage of FGF signaling at E13.5 results in an arrest
of branching activity associated at the cellular level with strong
165N. Patel et al. / Developmental Biology 358 (2011) 156–167ectopic expression of Axin2 and Cp2l1 in epithelial endbuds. We ﬁrst
tested whether ectopic expression of Cp2l1 in SU5402-treated end-
buds was decreased, or even rescued, in the presence of recombinant
sFRP1. Addition of sFRP1 protein to SGs cultured with SU5402 did
not lead to a change in Cp2l1 expression pattern, as the same strong
Cp2l1 expression was observed in endbuds of (SU5402+sFRP1)- and
SU5402-treated SMGs (Fig. 6E). We then analyzed the levels of Axin2
and Cp2l1 expression in SU5402- and (SU5402+sFRP1)-treated SGs.
In the presence of SU5402, Axin2 and Cp2l1 expression was increased
by 2370% and 1409% respectively (Fig. 6F). Although levels of Axin2
and Cp2l1 expression dropped in the presence of SU5402+sFRP1 by
36% and 33% respectively, they were still considerably higher than
levels of Axin2 and Cp2l1 expression found in WT SMGs, therefore
leading to a partial rescue of Wnt signaling up-regulation.
Discussion
Wnt/β-catenin signaling inhibits branching and promotes duct
maturation
Our analysis of Axin2lacZ sublingual/submandibular SGs shows that
activation of the Wnt/β-catenin signaling pathway is dynamic during
SG embryogenesis. Canonical Wnt activity ﬁrst occurs in the
condensed mesenchyme and subsequently localizes to the ductal
structures in the developing epithelium. Absence of Wnt/β-catenin
signaling in the epithelium of early developing SGs is in sharp contrast
with observations made in other branching organs. Wnt/β-catenin
activity was detected in the epithelial compartment of the lung (De
Langhe et al., 2005; Okubo and Hogan, 2004; Shu et al., 2005), kidney
(Bridgewater et al., 2008; Iglesias et al., 2007; Jho et al., 2002) and
mammary gland (Boras-Granic et al., 2006; Chu et al., 2004) from the
beginning of their embryonic development. Our loss and gain of
function of Wnt/β-catenin signaling both point to an inhibitory
function of the Wnt/β-catenin pathway on branching morphogenesis.
Constitutive activation of Wnt/β-catenin signaling, achieved with
either SB415286 or LiCl, at the initial bud or pseudoglandular stages,
led to a complete arrest of branching. Ectopic activation of this
pathway in the epithelium was sufﬁcient to inhibit branching,
without affecting epithelial cell proliferation, leading to oversized
endbuds. These endbuds completely lacked clefts at their tip,
suggesting that active Wnt/β-catenin signaling in epithelial endbuds
prevents cleft formation. Cleft formation can be divided into two
biochemically distinct steps: cleft initiation and cleft progression
(Daley et al., 2009); active Wnt/β-catenin signaling in the epithelium
appears to have a negative effect on cleft initiation. Conversely,
inhibition of Wnt/β-catenin signaling in the condensed mesenchyme
by means of either Dkk1 or sFRP1 recombinant protein promoted
epithelial branching, indicating that Wnt/β-catenin signaling acts as
an inhibitor of branching morphogenesis in the two tissues of the SG.
While this study was under review, another study (Haara et al., 2011)
reported that both in vitro treatment of SMGs with the Wnt signaling
inhibitors XAV939 and CK-I and mesenchymal conditional deletion of
β-catenin in vivo in the Dermo-Cre+; β-catenin−/ﬂ mice lead to
reduced epithelial branching and growth. Previous studies have
reported that Dermo-Cre+; β-catenin−/ﬂ mice have a defective
development of the mandible, which is very short (De Langhe et al.,
2008) and the shortening of the mandible has previously been shown
to correlate with salivary gland defects (Melnick et al., 2006). Our
results are consistent with data obtained in the lung and lacrimal
gland showing a negative effect of Wnt/β-catenin signaling on
epithelial branching (Dean et al., 2005). Around the mid stages of
branching morphogenesis, Wnt/β-catenin signaling is activated in
ductal epithelial structures. Although the timing coincideswith lumen
formation, activation of this pathway does not seem to be essential for
lumen formation, as some ductal cells switch on this pathway after
lumen formation, hence suggesting that it is involved in ductalmaturation. Consistent with this, salivary glands lacking GSK3β
function and consequently constitutively activating Wnt/β-catenin
signaling in the epithelium display normal lumen formation.
FGF signaling negatively regulates both canonical and non-canonical
Wnt signaling in the epithelium
Our results reveal that during normal development of the SMG,
activation ofWnt/β-catenin signaling in the epithelium is inhibited by
FGF signaling. Furthermore, FGF signaling also appears to inhibit non-
canonical Wnt signaling in epithelial cells. Regarding the inhibition of
the non-canonical Wnt pathway, we have an array of indirect
evidence. First, the expression pattern of Cp2l1, a known target of
Wnt signaling does not match Axin2lacZ expression, secondly, the non-
canonicalWnt5b ligand is expressed in a similar fashion to Cp2l1, and
thirdly, alterations of the Cp2l1 expression domain in inhibitor
experiments are matched by similar alterations of the Wnt5b
expression domain. These data suggest that in the SMG, non-canonical
Wnt signaling promotes ductal maturation. Intriguingly, although
Cp2l1 function is probably required from around the time of lumen
formation, expression of Cp2l1 is found as early as the initial bud stage
of SG development, marking presumptive ducts and providing
evidence of a ductal identity prior to histological signs of ductal
differentiation.
In the absence of FGF signaling, dramatic expansion of Cp2l1
expression to the neighboring endbud cells suggests that most endbud
cells have the potential to acquire a ductal identity. We can speculate
that endbud cells ectopically expressing Cp2l1 are cells already engaged
in apathway leading toductal identity, in otherwords, that they are cells
committed to shortly become ductal cells. How glandular ducts are
generated during branching morphogenesis is an interesting and still
unanswered question. One can think of at least three ways of forming
ducts: 1) ducts are separate entities that elongate to eventually grow
into the entire ductal network, 2) ducts originate from endbuds, which
are highly proliferative structures that leave behind a trail of ductal cells
as they invade the stroma, 3) ducts form by a combination of the two
previously cited mechanisms (Lu et al., 2006). Fate and lineages of
salivary gland endbud cells have not yet been explored, however, our
data support the idea that duringbranchingmorphogenesis, at least part
of theducts is generatedbyendbudcells, sincemostendbudcells appear
competent to switch on Cp2l1, a marker of ductal differentiation.
Interestingly, our experiments uncovered a distinct population of
endbud cells that behave differently from other endbud cells. This
epithelial cell population, a few cell layers thick, was located at the
periphery of endbuds lacking FGF signaling. In contrast to other endbud
cells, these cells ectopically expressed neither Cp2l1 nor Wnt5b,
implying that either a component of non-canonical Wnt signaling is
missing in these cells or that another pathway inhibits expression of
Cp2l1. This sub-population of endbud cells included the layer of
epithelial cells attached to the basementmembrane,whose cells display
a characteristic columnar shape. This cell layer has been proposed to
have a cell fate distinct from other endbud cells as it expresses the
neonatal acinar marker B1, which suggests that these cells are the
precursors of the secretory acinar cells (Walker et al., 2008).
Our results suggest that FGF signaling controls the two branches of
Wnt signaling at least in part through the Wnt secreted inhibitor
sFRP1, as sFRP1 is a target of FGF signaling in epithelial endbuds, and
recombinant sFRP1 is capable of decreasing expression of both Axin2
and Cp2l1 in in vitro cultures of SMGs. Connection between FGF and
Wnt signaling has previously been reported in the literature with FGF
signaling found to suppress Wnt signaling in murine eyelid epithe-
lium through sFRP1 expression (Huang et al., 2009). Considering that
sFRP1 expression is restricted to epithelial endbuds and that FGF
signaling has an inhibitory effect on canonical and non-canonical Wnt
signaling in both endbuds and ducts, it is likely that FGF signaling
inhibits Wnt signaling only in part through sFRP1. The fact that
Fig. 7. Model of FGF-Wnt signaling interactions during SMG branching morphogenesis. (A) In WT SMG epithelium Cp2l1 is expressed in presumptive ducts (blue) and groups of
endbud cells at the endbud/duct junction. In endbud cells (pink), FGF signaling represses canonical Wnt signaling (CWS), which inhibits branching morphogenesis. FGF-dependent
Wnt/β-catenin inhibition in endbudsmay bemediated by sFRP1, which a target of FGF signaling. FGF signaling may also inhibitWnt/β-catenin signaling in endbuds through a sFRP1-
independent mechanism. In endbud cells, FGF signaling also inhibits Cp2l1 expression. Our data suggest that Cp2l1 is a target of non-canonical Wnt signaling (NCWS) and that FGF
signaling controls Cp2l1 expression via the non-canonical Wnt5b ligand. FGF signaling may also inhibit NCWS through sFRP1 expression. FGF/Wnt interactions are not limited to the
endbuds as FGF signaling appears to attenuateWnt5b and Cp2l1 expression in presumptive ducts. FGF signaling represses lumen formation in the epithelium. (B) Inhibition of FGF
signaling with SU5402 leads to strong activation of CWS as well as ectopic expression ofWnt5b and Cp2l1 in endbud cells, with the exception of the outermost layers of endbud cells
(gray area), which do not expressWnt5b and Cp2l1. (C) Constitutive activation ofWnt/β-catenin signaling through inhibition of Gsk3β leads to enlarged buds resulting from a failure
of cleft formation. Oversized buds display ectopic patchy expression of Cp2l1 in a small, variable, central domain of endbuds (patterned area). It is likely that this abnormal Cp2l1
expression domain, which can display varied shapes, results from the expansion of the initial Cp2l1 expression domain, following the increase in size of the endbud.
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Cp2l1 in SMGs lacking FGF signaling supports this hypothesis.
FGF signaling represses lumen formation
Our study uncovers FGF signaling as a major regulator of lumen
formation during salivary gland development. FGF signaling inhibits
lumen formation in endbuds while it slows down lumen formation in
presumptive ducts. As previously discussed, ectopic lumen formation
in the absence of FGF signaling is not due to extensive activation of
Wnt/β-catenin signaling. It is also likely that is not due to activation
of non-canonical Wnt signaling, since in absence of FGF signaling,
ectopic lumina form in the outermost cell layers of endbuds, where
Cp2l1 is not ectopically expressed. This particular case illustrates that
lumen formation can occur in epithelial areas that are devoid of Cp2l1
expression, hence that expression of Cp2l1 is not a prerequisite for
lumen formation. The inhibition of lumen formation by FGF signaling
raises an interesting question regarding the control of lumen
formation: is lumen formation normally initiated via repression of
FGF signaling in the developing SMG? Our knowledge of the control of
lumen formation is very limited, with only one study (Hashizume and
Hieda, 2006) reporting that Shh protein promotes epithelial cell
polarization and duct formation; the data presented here open up
new avenues of research.
Ectopic expression of the ductal marker Cp2l1 associated with
abnormal lumen formation suggests that endbud cells assume a
ductal fate in absence of FGF signaling. Consistent with this, the active
form of caspase 3 was found in cells of endbuds devoid of FGF
signaling, whereas caspase 3 is normally not detected in endbuds,
which are believed to hollow out through a caspase-independent
mechanism (Melnick et al., 2001).
To summarize, during normal SMG development, FGF signaling
inhibits both canonical and non-canonical Wnt signaling in endbuds
through induction of the Wnt antagonist sFRP1 (Fig. 7A). Non-
canonical Wnt signaling is responsible for expression of the ductal
marker Cp2l1, via the Wnt ligand Wnt5b, while Wnt/β-catenin
signaling inhibits branching morphogenesis, possibly by impairing
cleft initiation. FGF signaling also attenuates Wnt signaling in ducts
through an unknown mechanism, which could also be used in
endbuds. In the absence of FGF signaling, endbud cells ectopically
activate both canonical and non-canonical Wnt signaling leading toectopic expression of Cp2l1, with the exception of the outermost
endbud cell layers (Fig. 7B). In absence of GSK3β activity, endbuds are
oversized due to continued cell proliferation in absence of cleft
formation. The Cp2l1 expression domain is expanded, displaying
varied shapes and salt and pepper expression of Cp2l1 that are likely
to result from the increase in size of the bud leading to an expansion of
the normal Cp2l1 expression domain.
Collectively, our data show that during normal development,
ductal fate is repressed in endbud cells. FGF/Wnt interaction is crucial
to maintain endbuds in an undifferentiated state and allow correct
timing of ductal lumenization. These ﬁndings provide a mechanism
for understanding how epithelial differentiation is controlled during
branchingmorphogenesis so that at the developing front, endbuds are
maintained undifferentiated while ductal structures left behind are
allowed to differentiate.
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